Setting

Asia Pacific Autoimmune Disease Diagnostics Market 2021-2031 by Product (Assay Kits & Consumables, Analyzers & Instruments), Test Type (Autoantibodies and Immunologic, Inflammatory Marker, Routine Laboratory, Others), Disease Type (Systemic, Localized), Gender (Female, Male), Age (<44, 44-64, >64), End User (Hospitals, Clinics, Diagnostic Labs), and Country: Trend Forecast and Growth Opportunity

Published: 30 Jan 2022 | Report Code: 10248353 | Pages: 131

Asia Pacific autoimmune disease diagnostics market will grow by 9.7% annually with a total addressable market cap of $19.06 billion over 2022-2031 owing to the growing prevalence of autoimmune diseases, the strong investment in research and development activities, the rise in technological advancements, increasing patient awareness and healthcare expenditure, and favorable government policies. Highlighted with 35 tables and 70 figures, this 131-page report “Asia Pacific Autoimmune Disease Diagnostics Market 2021-2031 by Product (Assay Kits & Consumables, Analyzers & Instruments), Test Type (Autoantibodies and Immunologic, Inflammatory Marker, Routine Laboratory, Others), Disease Type (Systemic, Localized), Gender (Female, Male), Age (<44, 44-64, >64), End User (Hospitals, Clinics, Diagnostic Labs), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific autoimmune disease diagnostics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia Pacific autoimmune disease diagnostics market in every aspect of the classification from perspectives of Product, Test Type, Disease Type, Gender, Age, End User, and Country. Based on Product, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Assay Kits & Consumables • Analyzers & Instruments Based on Test Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Autoantibodies and Immunologic Tests o Antinuclear Antibody Tests o Anti-cyclic Citrullinated Peptide o Enzyme-Linked Immunosorbent Assay (ELISA) o Rheumatoid Factor o Thyroid Antibody Tests o Other Autoantibodies and Immunologic Tests • Inflammatory Marker Tests o C-Reactive Protein (CRP) o Erythrocyte Sedimentation Rate (ESR) o Other Inflammatory Marker Tests • Routine Laboratory Tests o Urinalysis o Complete Blood Count (CBC) Tests o Other Routine Laboratory Tests • Other Test Types Based on Disease Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Systemic Autoimmune Disease o Rheumatoid Arthritis o Systemic Lupus Erythematosus (SLE) o Psoriasis/Psoriatic Arthritis o Other Systemic Autoimmune Diseases • Localized Autoimmune Disease o Thyroiditis o Multiple Sclerosis o Inflammatory Bowel Disease o Type 1 Diabetes o Other Localized Autoimmune Diseases Based on Gender, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Female Patients • Male Patients Based on Age, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • < 44 • 44 - 64 • > 64 Based on End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Hospitals • Clinics • Diagnostic Labs • Other End Users Geographically, the following national/local markets are fully investigated: • Japan • China • South Korea • Australia • India • Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines) For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of the regional market by country and split of key national markets by Product, Disease Type, and End User over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Selected Key Players: Abbott Laboratories Beckman Coulter, Inc. Biomerieux SA Bio-rad Laboratories Inc. F. Hoffmann-la Roche Ltd. Hemagen Diagnostics Inc. Myriad Genetics Inc. PerkinElmer Inc. (Euroimmun AG) Quest Diagnostics Inc. Siemens Healthineers Inc. Thermo Fisher Scientific Inc. Trinity Biotech PLC Werfen Company (Inova Diagnostics Inc.) (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Table Of Contents:

1 Introduction	8
1.1 Industry Definition and Research Scope	8
1.1.1 Industry Definition	8
1.1.2 Research Scope	9
1.2 Research Methodology	12
1.2.1 Overview of Market Research Methodology	12
1.2.2 Market Assumption	13
1.2.3 Secondary Data	13
1.2.4 Primary Data	13
1.2.5 Data Filtration and Model Design	14
1.2.6 Market Size/Share Estimation	15
1.2.7 Research Limitations	16
1.3 Executive Summary	17
2 Market Overview and Dynamics	20
2.1 Market Size and Forecast	20
2.1.1 Impact of COVID-19 on World Economy	21
2.1.2 Impact of COVID-19 on the Market	23
2.2 Major Growth Drivers	25
2.3 Market Restraints and Challenges	30
2.4 Emerging Opportunities and Market Trends	33
2.5 Porter’s Fiver Forces Analysis	37
3 Segmentation of Asia Pacific Market by Product	42
3.1 Market Overview by Product	42
3.2 Assay Kits & Consumables	44
3.3 Analyzers & Instruments	45
4 Segmentation of Asia Pacific Market by Test Type	46
4.1 Market Overview by Test Type	46
4.2 Autoantibodies and Immunologic Tests	48
4.2.1 Antinuclear Antibody Tests	50
4.2.2 Anti-cyclic Citrullinated Peptide	51
4.2.3 Enzyme-Linked Immunosorbent Assay (ELISA)	52
4.2.4 Rheumatoid Factor	53
4.2.5 Thyroid Antibody Tests	54
4.2.6 Other Autoantibodies and Immunologic Tests	55
4.3 Inflammatory Marker Tests	56
4.3.1 C-Reactive Protein (CRP)	58
4.3.2 Erythrocyte Sedimentation Rate (ESR)	59
4.3.3 Other Inflammatory Marker Tests	60
4.4 Routine Laboratory Tests	61
4.4.1 Urinalysis	63
4.4.2 Complete Blood Count (CBC) Tests	64
4.4.3 Other Routine Laboratory Tests	65
4.5 Other Test Types	66
5 Segmentation of Asia Pacific Market by Disease Type	67
5.1 Market Overview by Disease Type	67
5.2 Systemic Autoimmune Disease	69
5.2.1 Rheumatoid Arthritis	71
5.2.2 Systemic Lupus Erythematosus (SLE)	72
5.2.3 Psoriasis/Psoriatic Arthritis	73
5.2.4 Other Systemic Autoimmune Diseases	74
5.3 Localized Autoimmune Disease	75
5.3.1 Thyroiditis	77
5.3.2 Multiple Sclerosis	78
5.3.3 Inflammatory Bowel Disease	79
5.3.4 Type 1 Diabetes	80
5.3.5 Other Localized Autoimmune Diseases	81
6 Segmentation of Asia Pacific Market by Gender	82
6.1 Market Overview by Gender	82
6.2 Female Patients	84
6.3 Male Patients	85
7 Segmentation of Asia Pacific Market by Age	86
7.1 Market Overview by Age	86
7.2 < 44	88
7.3 44 - 64	89
7.4 > 64	90
8 Segmentation of Asia Pacific Market by End User	91
8.1 Market Overview by End User	91
8.2 Hospitals	93
8.3 Clinics	94
8.4 Diagnostic Labs	95
8.5 Other End Users	96
9 Asia-Pacific Market 2021-2031 by Country	97
9.1 Overview of Asia-Pacific Market	97
9.2 Japan	100
9.3 China	103
9.4 Australia	105
9.5 India	107
9.6 South Korea	109
9.7 Rest of APAC Region	111
10 Competitive Landscape	113
10.1 Overview of Key Vendors	113
10.2 New Product Launch, Partnership, Investment, and M&A	116
10.3 Company Profiles	117
Abbott Laboratories	117
Beckman Coulter, Inc.	119
Biomerieux SA	120
Bio-rad Laboratories Inc.	121
F. Hoffmann-la Roche Ltd.	122
Hemagen Diagnostics Inc.	123
Myriad Genetics Inc.	124
PerkinElmer Inc. (Euroimmun AG)	125
Quest Diagnostics Inc.	126
Siemens Healthineers Inc.	127
Thermo Fisher Scientific Inc.	128
Trinity Biotech PLC	129
Werfen Company (Inova Diagnostics Inc.)	130
RELATED REPORTS	131

List Of Tables:


Table 1.  Snapshot of Asia Pacific Autoimmune Disease Diagnostics Market in Balanced Perspective, 2021-2031	18
Table 2. World Economic Outlook, 2021-2031	22
Table 3. World Health Spending by Region, $ bn, 2013-2020	29
Table 4.  Main Product Trends and Market Opportunities in Asia Pacific Autoimmune Disease Diagnostics Market	33
Table 5. Asia Pacific Autoimmune Disease Diagnostics Market by Product, 2021-2031, $ mn	42
Table 6. Asia Pacific Autoimmune Disease Diagnostics Market by Test Type, 2021-2031, $ mn	46
Table 7. Asia Pacific Autoimmune Disease Diagnostics Market: Autoantibodies and Immunologic Tests by Type, 2021-2031, $ mn	49
Table 8. Asia Pacific Autoimmune Disease Diagnostics Market: Inflammatory Marker Tests by Type, 2021-2031, $ mn	57
Table 9. Asia Pacific Autoimmune Disease Diagnostics Market: Routine Laboratory Tests by Type, 2021-2031, $ mn	62
Table 10. Asia Pacific Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, $ mn	67
Table 11. Asia Pacific Autoimmune Disease Diagnostics Market: Systemic Autoimmune Disease by Type, 2021-2031, $ mn	70
Table 12. Asia Pacific Autoimmune Disease Diagnostics Market: Localized Autoimmune Disease by Type, 2021-2031, $ mn	76
Table 13. Asia Pacific Autoimmune Disease Diagnostics Market by Gender, 2021-2031, $ mn	82
Table 14. Asia Pacific Autoimmune Disease Diagnostics Market by Age, 2021-2031, $ mn	86
Table 15. Asia Pacific Autoimmune Disease Diagnostics Market by End User, 2021-2031, $ mn	91
Table 16. APAC Autoimmune Disease Diagnostics Market by Country, 2021-2031, $ mn	98
Table 17. Japan Autoimmune Disease Diagnostics Market by Product, 2021-2031, $ mn	102
Table 18. Japan Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, $ mn	102
Table 19. Japan Autoimmune Disease Diagnostics Market by End User, 2021-2031, $ mn	102
Table 20. China Autoimmune Disease Diagnostics Market by Product, 2021-2031, $ mn	104
Table 21. China Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, $ mn	104
Table 22. China Autoimmune Disease Diagnostics Market by End User, 2021-2031, $ mn	104
Table 23. Australia Autoimmune Disease Diagnostics Market by Product, 2021-2031, $ mn	106
Table 24. Australia Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, $ mn	106
Table 25. Australia Autoimmune Disease Diagnostics Market by End User, 2021-2031, $ mn	106
Table 26. India Autoimmune Disease Diagnostics Market by Product, 2021-2031, $ mn	108
Table 27. India Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, $ mn	108
Table 28. India Autoimmune Disease Diagnostics Market by End User, 2021-2031, $ mn	108
Table 29. South Korea Autoimmune Disease Diagnostics Market by Product, 2021-2031, $ mn	110
Table 30. South Korea Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, $ mn	110
Table 31. South Korea Autoimmune Disease Diagnostics Market by End User, 2021-2031, $ mn	110
Table 32. Autoimmune Disease Diagnostics Market in Rest of APAC by Country/Region, 2021-2031, $ mn	112
Table 33. Abbott Laboratories: Company Snapshot	117
Table 34. Abbott Laboratories: Business Segmentation	118
Table 35. Abbott Laboratories: Product Portfolio	118

List Of Figures:


Figure 1. Research Method Flow Chart	12
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation	15
Figure 3. Asia Pacific Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031	17
Figure 4. Asia Pacific Autoimmune Disease Diagnostics Market, 2021-2031, $ mn	20
Figure 5. Impact of COVID-19 on Business	23
Figure 6. Primary Drivers and Impact Factors of Asia Pacific Autoimmune Disease Diagnostics Market	25
Figure 7.  Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million	28
Figure 8. World Population 65 and Over, % of Total Population, 1950-2060	28
Figure 9. Primary Restraints and Impact Factors of Asia Pacific Autoimmune Disease Diagnostics Market	30
Figure 10. Investment Opportunity Analysis	34
Figure 11. Porter’s Fiver Forces Analysis of Asia Pacific Autoimmune Disease Diagnostics Market	37
Figure 12. Breakdown of Asia Pacific Autoimmune Disease Diagnostics Market by Product, 2021-2031, % of Revenue	43
Figure 13. Asia Pacific Addressable Market Cap in 2022-2031 by Product, Value ($ mn) and Share (%)	43
Figure 14. Asia Pacific Autoimmune Disease Diagnostics Market by Product: Assay Kits & Consumables, 2021-2031, $ mn	44
Figure 15. Asia Pacific Autoimmune Disease Diagnostics Market by Product: Analyzers & Instruments, 2021-2031, $ mn	45
Figure 16. Breakdown of Asia Pacific Autoimmune Disease Diagnostics Market by Test Type, 2021-2031, % of Sales Revenue	47
Figure 17. Asia Pacific Addressable Market Cap in 2022-2031 by Test Type, Value ($ mn) and Share (%)	47
Figure 18. Asia Pacific Autoimmune Disease Diagnostics Market by Test Type: Autoantibodies and Immunologic Tests, 2021-2031, $ mn	48
Figure 19. Asia Pacific Autoimmune Disease Diagnostics Market by Autoantibodies and Immunologic Tests: Antinuclear Antibody Tests, 2021-2031, $ mn	50
Figure 20. Asia Pacific Autoimmune Disease Diagnostics Market by Autoantibodies and Immunologic Tests: Anti-cyclic Citrullinated Peptide, 2021-2031, $ mn	51
Figure 21. Asia Pacific Autoimmune Disease Diagnostics Market by Autoantibodies and Immunologic Tests: Enzyme-Linked Immunosorbent Assay (ELISA), 2021-2031, $ mn	52
Figure 22. Asia Pacific Autoimmune Disease Diagnostics Market by Autoantibodies and Immunologic Tests: Rheumatoid Factor, 2021-2031, $ mn	53
Figure 23. Asia Pacific Autoimmune Disease Diagnostics Market by Autoantibodies and Immunologic Tests: Thyroid Antibody Tests, 2021-2031, $ mn	54
Figure 24. Asia Pacific Autoimmune Disease Diagnostics Market by Autoantibodies and Immunologic Tests: Other Autoantibodies and Immunologic Tests, 2021-2031, $ mn	55
Figure 25. Asia Pacific Autoimmune Disease Diagnostics Market by Test Type: Inflammatory Marker Tests, 2021-2031, $ mn	56
Figure 26. Asia Pacific Autoimmune Disease Diagnostics Market by Inflammatory Marker Tests: C-Reactive Protein (CRP), 2021-2031, $ mn	58
Figure 27. Asia Pacific Autoimmune Disease Diagnostics Market by Inflammatory Marker Tests: Erythrocyte Sedimentation Rate (ESR), 2021-2031, $ mn	59
Figure 28. Asia Pacific Autoimmune Disease Diagnostics Market by Inflammatory Marker Tests: Other Inflammatory Marker Tests, 2021-2031, $ mn	60
Figure 29. Asia Pacific Autoimmune Disease Diagnostics Market by Test Type: Routine Laboratory Tests, 2021-2031, $ mn	61
Figure 30. Asia Pacific Autoimmune Disease Diagnostics Market by Routine Laboratory Tests: Urinalysis, 2021-2031, $ mn	63
Figure 31. Asia Pacific Autoimmune Disease Diagnostics Market by Routine Laboratory Tests: Complete Blood Count (CBC) Tests, 2021-2031, $ mn	64
Figure 32. Asia Pacific Autoimmune Disease Diagnostics Market by Routine Laboratory Tests: Other Routine Laboratory Tests, 2021-2031, $ mn	65
Figure 33. Asia Pacific Autoimmune Disease Diagnostics Market by Test Type: Other Test Types, 2021-2031, $ mn	66
Figure 34. Breakdown of Asia Pacific Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, % of Sales Revenue	68
Figure 35. Asia Pacific Addressable Market Cap in 2022-2031 by Disease Type, Value ($ mn) and Share (%)	68
Figure 36. Asia Pacific Autoimmune Disease Diagnostics Market by Disease Type: Systemic Autoimmune Disease, 2021-2031, $ mn	69
Figure 37. Asia Pacific Autoimmune Disease Diagnostics Market by Systemic Autoimmune Disease: Rheumatoid Arthritis, 2021-2031, $ mn	71
Figure 38. Asia Pacific Autoimmune Disease Diagnostics Market by Systemic Autoimmune Disease: Systemic Lupus Erythematosus (SLE), 2021-2031, $ mn	72
Figure 39. Asia Pacific Autoimmune Disease Diagnostics Market by Systemic Autoimmune Disease: Psoriasis/Psoriatic Arthritis, 2021-2031, $ mn	73
Figure 40. Asia Pacific Autoimmune Disease Diagnostics Market by Systemic Autoimmune Disease: Other Systemic Autoimmune Diseases, 2021-2031, $ mn	74
Figure 41. Asia Pacific Autoimmune Disease Diagnostics Market by Disease Type: Localized Autoimmune Disease, 2021-2031, $ mn	75
Figure 42. Asia Pacific Autoimmune Disease Diagnostics Market by Localized Autoimmune Disease: Thyroiditis, 2021-2031, $ mn	77
Figure 43. Asia Pacific Autoimmune Disease Diagnostics Market by Localized Autoimmune Disease: Multiple Sclerosis, 2021-2031, $ mn	78
Figure 44. Asia Pacific Autoimmune Disease Diagnostics Market by Localized Autoimmune Disease: Inflammatory Bowel Disease, 2021-2031, $ mn	79
Figure 45. Asia Pacific Autoimmune Disease Diagnostics Market by Localized Autoimmune Disease: Type 1 Diabetes, 2021-2031, $ mn	80
Figure 46. Asia Pacific Autoimmune Disease Diagnostics Market by Localized Autoimmune Disease: Other Localized Autoimmune Diseases, 2021-2031, $ mn	81
Figure 47. Breakdown of Asia Pacific Autoimmune Disease Diagnostics Market by Gender, 2021-2031, % of Revenue	83
Figure 48. Asia Pacific Addressable Market Cap in 2022-2031 by Gender, Value ($ mn) and Share (%)	83
Figure 49. Asia Pacific Autoimmune Disease Diagnostics Market by Gender: Female Patients, 2021-2031, $ mn	84
Figure 50. Asia Pacific Autoimmune Disease Diagnostics Market by Gender: Male Patients, 2021-2031, $ mn	85
Figure 51. Breakdown of Asia Pacific Autoimmune Disease Diagnostics Market by Age, 2021-2031, % of Revenue	87
Figure 52. Asia Pacific Addressable Market Cap in 2022-2031 by Age, Value ($ mn) and Share (%)	87
Figure 53. Asia Pacific Autoimmune Disease Diagnostics Market by Age: < 44, 2021-2031, $ mn	88
Figure 54. Asia Pacific Autoimmune Disease Diagnostics Market by Age: 44 - 64, 2021-2031, $ mn	89
Figure 55. Asia Pacific Autoimmune Disease Diagnostics Market by Age: > 64, 2021-2031, $ mn	90
Figure 56. Breakdown of Asia Pacific Autoimmune Disease Diagnostics Market by End User, 2021-2031, % of Revenue	91
Figure 57. Asia Pacific Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%)	92
Figure 58. Asia Pacific Autoimmune Disease Diagnostics Market by End User: Hospitals, 2021-2031, $ mn	93
Figure 59. Asia Pacific Autoimmune Disease Diagnostics Market by End User: Clinics, 2021-2031, $ mn	94
Figure 60. Asia Pacific Autoimmune Disease Diagnostics Market by End User: Diagnostic Labs, 2021-2031, $ mn	95
Figure 61. Asia Pacific Autoimmune Disease Diagnostics Market by End User: Other End Users, 2021-2031, $ mn	96
Figure 62. Breakdown of APAC Autoimmune Disease Diagnostics Market by Country, 2021 and 2031, % of Revenue	98
Figure 63. Contribution to APAC 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)	99
Figure 64.  Autoimmune Disease Diagnostics Market in Japan, 2021-2031, $ mn	101
Figure 65.  Autoimmune Disease Diagnostics Market in China, 2021-2031, $ mn	103
Figure 66.  Autoimmune Disease Diagnostics Market in Australia, 2021-2031, $ mn	105
Figure 67.  Autoimmune Disease Diagnostics Market in India, 2021-2031, $ mn	107
Figure 68.  Autoimmune Disease Diagnostics Market in South Korea, 2021-2031, $ mn	109
Figure 69.  Autoimmune Disease Diagnostics Market in Rest of APAC, 2021-2031, $ mn	111
Figure 70. Growth Stage of Asia Pacific Autoimmune Disease Diagnostics Industry over the Forecast Period	113
Key Players:
 
Abbott Laboratories
Beckman Coulter, Inc.
Biomerieux SA
Bio-rad Laboratories Inc.
F. Hoffmann-la Roche Ltd.
Hemagen Diagnostics Inc.
Myriad Genetics Inc.
PerkinElmer Inc. (Euroimmun AG)
Quest Diagnostics Inc.
Siemens Healthineers Inc.
Thermo Fisher Scientific Inc.
Trinity Biotech PLC
Werfen Company (Inova Diagnostics Inc.)
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)